Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global orthobiologics market. The report provides market landscape, competitive landscape and market trends information on the orthobiologics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Bone Allografts, Bone Graft Substitutes, Bone Growth Stimulators, DBM and Viscosupplementation.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within orthobiologics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Genzyme Corporation, DePuy and Synthes.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the orthobiologics market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the orthobiologics market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global orthobiologics market and the factors shaping it.

Table Of Contents

1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction and Overview 8
2.1 Introduction 8
2.2 GlobalData Report Guidance 8
3 Orthobiologics - Device Overview 9
3.1 Orthobiologics Market - Market Segmentation 9
3.1.1 Bone Allografts 9
3.1.2 Bone Graft Substitutes 10
3.1.3 Bone Growth Stimulators 11
3.1.4 Viscosupplementation 12
3.2 Applications 12
3.2.1 Foot and Ankle Surgery 12
3.2.2 Spinal Fusion 13
3.2.3 Knee Surgery 13
3.2.4 Shoulder Surgery 13
3.2.5 Hip Surgery 13
3.2.6 Fractures and Bone Injuries 13
3.2.7 Bone Tumors 14
4 Orthobiologics Market - Global Market Characterization 15
4.1 Orthobiologics Market, Global, Revenue ($bn), Historic, 2003 - 2010 15
4.2 Orthobiologics Market, Global, Revenue ($bn), Forecast, 2010 - 2017 16
4.3 Global Orthobiologics Market, Key Trends 17
4.3.1 Despite an Increase in the Number of Musculoskeletal Tissue Donors, There is Still a Shortage of Bone Allografts in the Market 17
4.3.2 Orthobiologics Market is Facing Consolidation 18
4.3.3 Surgeries Involving Orthobiologic Material are Increasing Through Medical Tourism 18
4.4 Global Orthobiologics, Market Dynamics 19
4.4.1 Market Drivers 19
4.4.2 Market Restraints 23
5 Global Orthobiologics Market - Analysis By Segment 25
5.1 Bone Graft Substitutes Market, Global, Revenue ($m), Historic, 2003 - 2010 25
5.2 Bone Graft Substitutes Market, Global, Revenue ($m), Forecast, 2010 - 2017 26
5.2.1 Market Driver 27
5.2.2 Market Restraints 29
5.3 Viscosupplementation Market, Global, Revenue ($m), Historic, 2003 - 2010 32
5.4 Viscosupplementation Market, Global, Revenue ($m), Forecast, 2010 - 2017 33
5.4.1 Market Driver 34
5.4.2 Market Restraint 36
5.5 Bone Allografts Market, Global, Revenue ($m), Historic, 2003 - 2010 37
5.6 Bone Allografts Market, Global, Revenue ($m), Forecast, 2010 - 2017 38
5.6.1 Market Driver 39
5.6.2 Market Restraint 39
5.7 Bone Growth Stimulators Market, Global, Revenue ($m), Historic, 2003 - 2010 40
5.8 Bone Growth Stimulators Market, Global, Revenue ($m), Forecast, 2010 - 2017 41
5.8.1 Market Driver 42
5.8.2 Market Restraint 42
6 Global Orthobiologics Market - Analysis and Forecasts by Country 43
6.1 Orthobiologics Market, The US, Revenue ($m), Historic, 2003 - 2010 43
6.2 Orthobiologics Market, The US, Revenue ($m), Forecast, 2010 - 2017 44
6.3 Orthobiologics Market, Canada, Revenue ($m), Historic, 2003 - 2010 45
6.4 Orthobiologics Market, Canada, Revenue ($m), Forecast, 2010 - 2017 46
6.5 Orthobiologics Market, The UK, Revenue ($m), Historic, 2003 - 2010 47
6.6 Orthobiologics Market, The UK, Revenue ($m), Forecast, 2010 - 2017 48
6.7 Orthobiologics Market, Germany, Revenue ($m), Historic, 2003 - 2010 49
6.8 Orthobiologics Market, Germany, Revenue ($m), Forecast, 2010 - 2017 50
6.9 Orthobiologics Market, France, Revenue ($m), Historic, 2003 - 2010 51
6.10 Orthobiologics Market, France, Revenue ($m), Forecast, 2010 - 2017 52
6.11 Orthobiologics Market, Italy, Revenue ($m), Historic, 2003 - 2010 53
6.12 Orthobiologics Market, Italy, Revenue ($m), Forecast, 2010 - 2017 54
6.13 Orthobiologics Market, Spain, Revenue ($m), Historic, 2003 - 2010 55
6.14 Orthobiologics Market, Spain, Revenue ($m), Forecast, 2010 - 2017 56
6.15 Orthobiologics Market, Japan, Revenue ($m), Historic, 2003 - 2010 57
6.16 Orthobiologics Market, Japan, Revenue ($m), Forecast, 2010 - 2017 58
6.17 Orthobiologics Market, China, Revenue ($m), Historic, 2003 - 2010 60
6.18 Orthobiologics Market, China, Revenue ($m), Forecast, 2010 - 2017 61
6.19 Orthobiologics Market, India, Revenue ($m), Historic, 2003 - 2010 62
6.20 Orthobiologics Market, India, Revenue ($m), Forecast, 2010 - 2017 63
6.21 Orthobiologics Market, Australia, Revenue ($m), Historic, 2003 - 2010 64
6.22 Orthobiologics Market, Australia, Revenue ($m), Forecast, 2010 - 2017 65
6.23 Orthobiologics Market, Brazil, Revenue ($m), Historic, 2003 - 2010 66
6.24 Orthobiologics Market, Brazil, Revenue ($m), Forecast, 2010 - 2017 67
7 Global Orthobiologics Market - Competitive Assessment 68
7.1 Orthobiologics Market, Global, Key Company Share (%), 2010 68
7.2 Orthobiologics Market, Key Market Participants 69
7.2.1 Medtronic, Inc. 69
7.2.2 DePuy, Inc. 72
7.2.3 Genzyme Corporation 75
7.2.4 Synthes, Inc. 77
8 Global Orthobiologics Market - Pipeline Assessment 81
8.1 Orthobiologics, Pipeline Products, by Stage of Development, Global, 2011 81
8.2 Orthobiologic Pipeline Products, by Segment 81
8.2.1 Bone Allografts 81
8.2.2 Bone Graft Substitutes 85
8.2.3 Bone Growth Stimulators 91
8.2.4 Viscosupplementation 94
8.2.5 Other Orthobiologic Pipeline Products 95
9 Global Orthobiologics Market - Strategic Deals Analysis 99
9.1 Deals Overview, 2006 - 2011 99
9.2 Key Deals, Orthobiologics Market 100
9.2.1 Stryker to Acquire Orthovita 100
9.2.2 Johnson and Johnson Enters into an Agreement to Acquire Synthes 100
9.2.3 Sanofi-Aventis Completes Acquisition of Genzyme 100
9.2.4 Medtronic Completes Acquisition of Osteotech 101
9.2.5 Baxter International Completes Acquisition of ApaTech 101
10 Appendix 102
10.1 Market Definitions 103
10.1.1 Orthobiologics 103
10.2 Abbreviations (in alphabetical order) 104
10.3 Research Methodology 105
10.4 GlobalData Consulting 106
10.5 Contact Us 106
10.6 Disclaimer 107

1.1 List of Tables

Table 1: Orthobiologics Market, Global, Revenue ($bn), 2003 - 2010 15
Table 2: Orthobiologics Market, Global, Revenue ($bn), 2010 - 2017 16
Table 3: Number of Musculoskeletal Tissue Donors in the US, 2001 - 2007 17
Table 4: Cost Comparison of Orthopedic Procedures 18
Table 5: Studies Indicating Efficacy of Orthobiologic Products 19
Table 6: Prevalence of Arthritis and Arthritis-Attributable Activity Limitation Among Adults, US, 2003 - 2009 20
Table 7: Spinal Fusion Procedures Volumes (m), Global, 2006 - 2010 21
Table 8: Spinal Fusion Studies in Elderly Patients, 2006 - 2009 22
Table 9: Number of Orthopedic Surgeons in the US, 2002 - 2010 23
Table 10: Orthopedic Surgeons by Age Group, The US, 2010 24
Table 11: Bone Graft Substitutes Market, Global, Revenue ($m), 2003 - 2010 25
Table 12: Bone Graft Substitutes Market, Global, Revenue ($m), 2010 - 2017 26
Table 13: Bone Morphogenetic Proteins, Clinical Trials 27
Table 14: Synthetic Bone Graft Substitutes, Clinical Trials 28
Table 15: DBM, Clinical Trials 28
Table 16: Bone Graft Substitutes, Average Selling Price ($), the US, 2003-2010 29
Table 17: Viscosupplementation Market, Global, Revenue ($m), 2003 - 2010 32
Table 18: Viscosupplementation Market, Global, Revenue ($m), 2010 - 2017 33
Table 19: Studies Supporting Treatment of Ankle Osteoarthritis with Viscosupplements, 2006 - 2008 34
Table 20: Studies Supporting Treatment of Hip Osteoarthritis with Viscosupplements, 2006 - 2009 35
Table 21: Studies Supporting Treatment of Shoulder Osteoarthritis with Viscosupplements, 2008 - 2009 35
Table 22: Revenue ($m) and Average Selling Price ($), Viscosupplementation, The US, 2010 - 2017 36
Table 23: Bone Allografts, Global, Revenue ($m), 2003 - 2010 37
Table 24: Bone Allografts Market, Global, Revenue ($m), 2010 - 2017 38
Table 25: Bone Growth Stimulators Market, Global, Revenue ($m), 2003 - 2010 40
Table 26: Bone Growth Stimulators Market, Global, Revenue ($m), 2010 - 2017 41
Table 27: Number of Sports Related Injuries in the US (000s), 2007 - 2009 42
Table 28: Orthobiologics Market, The US, Revenue ($m), 2003 - 2010 43
Table 29: Orthobiologics Market, The US, Revenue ($m), 2010 - 2017 44
Table 30: Orthobiologics Market, Canada, Revenue ($m), 2003 - 2010 45
Table 31: Orthobiologics Market, Canada, Revenue ($m), 2010 - 2017 46
Table 32: Orthobiologics Market, The UK, Revenue ($m), 2003 - 2010 47
Table 33: Orthobiologics Market, The UK, Revenue ($m), 2010 - 2017 48
Table 34: Orthobiologics Market, Germany, Revenue ($m), 2003 - 2010 49
Table 35: Orthobiologics Market, Germany, Revenue ($m), 2010 - 2017 50
Table 36: Orthobiologics Market, France, Revenue ($m), 2003 - 2010 51
Table 37: Orthobiologics Market, France, Revenue ($m), 2010 - 2017 52
Table 38: Orthobiologics Market, Italy, Revenue ($m), 2003 - 2010 53
Table 39: Orthobiologics Market, Italy, Revenue ($m), 2010 - 2017 54
Table 40: Orthobiologics Market, Spain, Revenue ($m), 2003 - 2010 55
Table 41: Orthobiologics Market, Spain, Revenue ($m), 2010 - 2017 56
Table 42: Orthobiologics Market, Japan, Revenue ($m), 2003 - 2010 57
Table 43: Orthobiologics Market, Japan, Revenue ($m), 2010 - 2017 58
Table 44: Bone Graft Procedures in Japan, 1995 - 2004 59
Table 45: Orthobiologics Market, China, Revenue ($m), 2003 - 2010 60
Table 46: Orthobiologics Market, China, Revenue ($m), 2010 - 2017 61
Table 47: Orthobiologics Market, India, Revenue ($m), 2003 - 2010 62
Table 48: Orthobiologics Market, India, Revenue ($m), 2010 - 2017 63
Table 49: Orthobiologics Market, Australia, Revenue ($m), 2003 - 2010 64
Table 50: Orthobiologics Market, Australia, Revenue ($m), 2010 - 2017 65
Table 51: Orthobiologics Market, Brazil, Revenue ($m), 2003 - 2010 66
Table 52: Orthobiologics Market, Brazil, Revenue ($m), 2010 - 2017 67
Table 53: Orthobiologics Market, Global, Company Revenue ($m), 2010 68
Table 54: Key Products, Medtronic, Inc., 2011 69
Table 55: Key Products, DePuy, Inc., 2011 72
Table 56: Key Marketed Products, Genzyme Corporation, 2011 75
Table 57: Key Marketed Products, Synthes, Inc., 2011 77
Table 58: Orthobiologics, Pipeline by Stage, 2011 81
Table 59: Bone Allografts, Pipeline by Stage and Territory, 2011 81
Table 60: CR-Plug, Clinical Trial Details, 2011 82
Table 61: CR-Plug, Clinical Trial Details, 2011 83
Table 62: CR-Plug, Clinical Trial Details, 2011 84
Table 63: Bone Graft Substitutes, Pipeline by Stage and Territory, 2011 85
Table 64: AMPLEX Osteo-Promotive Bone Graft System, Clinical Trial Details, 2011 87
Table 65: Cerament Spine Support, Clinical Trial Details, 2011 89
Table 66: Amplify rhBMP-2, Clinical Trial Details, 2011 90
Table 67: Bone Growth Stimulators, Pipeline by Stage and Territory, 2011 91
Table 68: CartiStem, Clinical Trial Details, 2011 92
Table 69: Viscosupplementation, Pipeline by Stage and Territory, 2011 94
Table 70: Durolane, Clinical Trial Details, 2011 94
Table 71: Other Orthobiologic Products, Pipeline by Stage and Territory, 2011 95
Table 72: GelrinC, Clinical Trial Details, 2011 97
Table 73: Orthobiologics Market, Global, Key Deals Overview, 2006 - 2011* 99

1.2 List of Figures

Figure 1: Orthobiologics Market Segmentation 9
Figure 2: Applications of Orthobiologics 12
Figure 3: Orthobiologics Market, Global, Revenue ($bn), 2003 - 2010 15
Figure 4: Orthobiologics Market, Global, Revenue ($bn), 2010 - 2017 16
Figure 5: Number of Musculoskeletal Tissue Donors in the US, 2001 - 2007 17
Figure 6: Global Orthobiologics, Market Dynamics 19
Figure 7: Prevalence of Arthritis and Arthritis-Attributable Activity Limitation Among Adults, US, 2003 - 2009 20
Figure 8: Spinal Fusion Procedures Volumes (Millions), Global, 2006 - 2010 21
Figure 9: Orthopedic Surgeons by Age Group, The US, 2010 24
Figure 10: Bone Graft Substitutes Market, Global, Revenue ($m), 2003 - 2010 25
Figure 11: Bone Graft Substitutes Market, Global, Revenue ($m), 2010 - 2017 26
Figure 12: Viscosupplementation Market, Global, Revenue ($m), 2003 - 2010 32
Figure 13: Viscosupplementation Market, Global, Revenue ($m), 2010 - 2017 33
Figure 14: Revenue ($m) and Average Selling Price ($), Viscosupplementation, The US, 2010 - 2017 36
Figure 15: Bone Allografts, Global, Revenue ($m), 2003 - 2010 37
Figure 16: Bone Allografts Market, Global, Revenue ($m), 2010 - 2017 38
Figure 17: Bone Growth Stimulators Market, Global, Revenue ($m), 2003 - 2010 40
Figure 18: Bone Growth Stimulators Market, Global, Revenue ($m), 2010 - 2017 41
Figure 19: Number of Sports Related Injuries in the US (000s), 2007 - 2009 42
Figure 20: Orthobiologics Market, The US, Revenue ($m), 2003 - 2010 43
Figure 21: Orthobiologics Market, The US, Revenue ($m), 2010 - 2017 44
Figure 22: Orthobiologics Market, Canada, Revenue ($m), 2003 - 2010 45
Figure 23: Orthobiologics Market, Canada, Revenue ($m), 2010 - 2017 46
Figure 24: Orthobiologics Market, The UK, Revenue ($m), 2003 - 2010 47
Figure 25: Orthobiologics Market, The UK, Revenue ($m), 2010 - 2017 48
Figure 26: Orthobiologics Market, Germany, Revenue ($m), 2003 - 2010 49
Figure 27: Orthobiologics Market, Germany, Revenue ($m), 2010 - 2017 50
Figure 28: Orthobiologics Market, France, Revenue ($m), 2003 - 2010 51
Figure 29: Orthobiologics Market, France, Revenue ($m), 2010 - 2017 52
Figure 30: Orthobiologics Market, Italy, Revenue ($m), 2003 - 2010 53
Figure 31: Orthobiologics Market, Italy, Revenue ($m), 2010 - 2017 54
Figure 32: Orthobiologics Market, Spain, Revenue ($m), 2003 - 2010 55
Figure 33: Orthobiologics Market, Spain, Revenue ($m), 2010 - 2017 56
Figure 34: Orthobiologics Market, Japan, Revenue ($m), 2003 - 2010 57
Figure 35: Orthobiologics Market, Japan, Revenue ($m), 2010 - 2017 58
Figure 36: Orthobiologics Market, China, Revenue ($m), 2003 - 2010 60
Figure 37: Orthobiologics Market, China, Revenue ($m), 2010 - 2017 61
Figure 38: Orthobiologics Market, India, Revenue ($m), 2003 - 2010 62
Figure 39: Orthobiologics Market, India, Revenue ($m), 2010 - 2017 63
Figure 40: Orthobiologics Market, Australia, Revenue ($m), 2003 - 2010 64
Figure 41: Orthobiologics Market, Australia, Revenue ($m), 2010 - 2017 65
Figure 42: Orthobiologics Market, Brazil, Revenue ($m), 2003 - 2010 66
Figure 43: Orthobiologics Market, Brazil, Revenue ($m), 2010 - 2017 67
Figure 44: Orthobiologics Market, Global, Key Company Share (%), 2010 68
Figure 45: SWOT Analysis, Medtronic, Inc. 69
Figure 46: SWOT Analysis, Depuy Inc. 73
Figure 47: SWOT Analysis, Genzyme Corporation 75
Figure 48: SWOT Analysis, Synthes Inc. 78
Figure 49: Orthobiologics, Pipeline by Stage, 2011 81
Figure 50: Orthobiologics Market, Global, Key Deals Overview, 2006 - 2011* 99

Companies mentioned

Medtronic, Inc.
DePuy, Inc.
Genzyme Corporation
Synthes, Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Technology Breakthroughs in Spinal Implants (Technical Insights)

Technology Breakthroughs in Spinal Implants (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

Biomaterial innovations is a growth factor for spinal implant market This research service summarizes the technology breakthroughs in spinal implants with respect to biomaterial technologies such as metals; ...

Biomaterials Market for Implantable Devices (Material Type - Metals, Polymers, Ceramics and Natural, Applications - Cardiology, Orthopedics, Dental, Ophthalmology and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 201

Biomaterials Market for Implantable Devices (Material Type - Metals, Polymers, Ceramics and Natural, Applications - Cardiology, Orthopedics, Dental, Ophthalmology and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 201

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

The biomaterials market has been extensively analyzed on the basis of material types, their use in various healthcare applications, success rate and geographical reach. Material type segment includes metals, ...

Blood Substitute Partnering 2009-2014

Blood Substitute Partnering 2009-2014

  • $ 695
  • Industry report
  • April 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Blood Substitutes ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.